A novel diagnostic and prognostic biomarker FSD1L facilitates EMT and Lenvatinib resistance via the WNT/β-catenin pathway in hepatocellular carcinoma

Cellular Signalling 2026

View at publisher
Authors: Yang Zhou, Gangli Hu, Lin Zhou, Jian Zhou, Yong Jiang, Fang Luo
DOI: 10.1016/j.cellsig.2026.112514
Cited by: 1
References: 17

Fields of Study & Subjects

Wnt/β-catenin signaling in development and cancer Cancer Cells and Metastasis Fibroblast Growth Factor Research

Publication details

Journal / source
Cellular Signalling
Publisher
Elsevier BV
Volume
144
Pages
112514–112514
Publication date
3 April 2026
Language
EN